Song Yun Ju C, Lundvig Ditte M S, Huang Yue, Gai Wei Ping, Blumbergs Peter C, Højrup Peter, Otzen Daniel, Halliday Glenda M, Jensen Poul H
Prince of Wales Medical Research Institute, Randwick, New South Wales, Australia.
Am J Pathol. 2007 Oct;171(4):1291-303. doi: 10.2353/ajpath.2007.070201. Epub 2007 Sep 6.
p25alpha is an oligodendroglial protein that can induce aggregation of alpha-synuclein and accumulates in oligodendroglial cell bodies containing fibrillized alpha-synuclein in the neurodegenerative disease multiple system atrophy (MSA). We demonstrate biochemically that p25alpha is a constituent of myelin and a high-affinity ligand for myelin basic protein (MBP), and in situ immunohistochemistry revealed that MBP and p25alpha colocalize in myelin in normal human brains. Analysis of MSA cases reveals dramatic changes in p25alpha and MBP throughout the course of the disease. In situ immunohistochemistry revealed a cellular redistribution of p25alpha immunoreactivity from the myelin to the oligodendroglial cell soma, with no overall change in p25alpha protein concentration using immunoblotting. Concomitantly, an approximately 80% reduction in the concentration of full-length MBP protein was revealed by immunoblotting along with the presence of immunoreactivity for MBP degradation products in oligodendroglia. The oligodendroglial cell bodies in MSA displayed an enlargement along with the relocalization of p25alpha, and this was enhanced after the deposition of alpha-synuclein in the glial cytoplasmic inclusions. Overall, the data indicate that changes in the cellular interactions between MBP and p25alpha occur early in MSA and contribute to abnormalities in myelin and subsequent alpha-synuclein aggregation and the ensuing neuronal degeneration that characterizes this disease.
p25α是一种少突胶质细胞蛋白,可诱导α-突触核蛋白聚集,并在神经退行性疾病多系统萎缩(MSA)中积聚在含有纤维化α-突触核蛋白的少突胶质细胞体中。我们通过生化方法证明p25α是髓磷脂的组成成分,也是髓磷脂碱性蛋白(MBP)的高亲和力配体,原位免疫组化显示在正常人类大脑中MBP和p25α在髓磷脂中共定位。对MSA病例的分析揭示了疾病过程中p25α和MBP的显著变化。原位免疫组化显示p25α免疫反应性从髓磷脂向少突胶质细胞胞体发生细胞重新分布,而免疫印迹显示p25α蛋白浓度没有总体变化。同时,免疫印迹显示全长MBP蛋白浓度降低了约80%,并且在少突胶质细胞中存在MBP降解产物的免疫反应性。MSA中的少突胶质细胞体随着p25α的重新定位而增大,并且在α-突触核蛋白沉积在胶质细胞质内含物后这种增大更加明显。总体而言,数据表明MBP和p25α之间的细胞相互作用变化在MSA早期就已发生,并导致髓磷脂异常以及随后的α-突触核蛋白聚集和随之而来的神经元变性,这些是该疾病的特征。